Home / KEEP BUT DO NOT DISPLAY (page 23)

KEEP BUT DO NOT DISPLAY

Whey Protein Helps Control Blood Sugar

And consuming whey protein may even help increase insulin production. "Consumption of whey protein shortly before a high-glycemic index breakfast increased the early and late post-meal insulin secretion, improved GLP-1 responses and reduced post-meal blood sugar levels in type 2 diabetic patients," the authors wrote. "Whey protein may therefore represent …

Read More »

Lifestyle, Metformin, Delay Diabetes

New data from the ongoing US Diabetes Prevention Program (DPP) show that randomizing overweight or obese people at high risk for type 2 diabetes to intensive lifestyle change or giving them the oral agent metformin can reduce or delay the development of the disease for as long as 15 years. …

Read More »

Improved Glycemic Control Cuts CV Risk

Among patients with type 2 diabetes who start taking insulin, those who attain good glycemic control are less likely to have a major adverse cardiac event (MACE) in the medium term than those who fail to achieve this, a new study suggests. The findings come from the Cardiovascular Risk Evaluation …

Read More »

Bionic Pancreas Effective for Type 1’s

FDA Approves Inhaled Insulin Afrezza for Diabetes. MannKind Corporation today announced that the FDA has approved AFREZZA® (insulin human) Inhalation Powder to improve glycemic control in adult patients with diabetes mellitus. More news to come. Bionic Pancreas Effective for Type 1’s. See this week’s Item #9.

Read More »

Lorcaserin Improved Glucose Control Regardless of Weight Loss

A study of 509 type 2 diabetes patients found that lorcaserin was more effective than diet and exercise alone in reducing A1C levels regardless of whether the patients lost weight. The patients, randomly assigned to either lorcaserin or placebo along with diet and exercise, had A1c levels between 7% and …

Read More »

Diabetes Patients Show Better Adherence for Statin Therapy

Patients with heart disease or diabetes were more likely than those without the conditions to remain on statin therapy, according to a study. Among patients without heart disease or diabetes, those who were most likely to continue taking statins were overweight/obese or former smokers. The researchers also found that heavy …

Read More »

ADA: Walkable Neighborhoods Cut Diabetes Rates

Residents of areas that encourage walking also have lower obesity rates. Those are the finding from two studies that showed those living in an area that encourages walking are also three times more likely to walk or bike and half as likely to drive to get from one place to …

Read More »